/PRNewswire/ Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem, today announced its 2021 Portfolio of 15 promising new companies..
/PRNewswire/ Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem, today announced its 2021 Portfolio of 15 promising new companies..
Innocan Pharma operates three primary and distinct segments: research and development (R&D) of CBD-loaded exosomes, R&D of the use of CBD-loaded liposomes, and commercialization and sale of branded CBD-integrated pharmaceutical and topical treatment products